Craft
  • Home
  •  / Acticor Biotech
Acticor Biotech

Acticor Biotech

Total Funding

$33.3 M

Acticor Biotech Summary

Company summary

Overview
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. The Company develops a biologic drug candidate based on academic research on a platelet glycoprotein called GPVI.
Type
Private
Status
Active
Founded
2013
HQ
Paris, FR | view all locations
Website
https://acticor-biotech.com/
Cybersecurity rating
Sectors

Key people

  • Alain Munoz

    Alain Munoz, Chairman of the Board and Independent Member

    • Andrea Comenducci

      Andrea Comenducci, Medical Director

    • Catherine Boule

      Catherine Boule, Director

      • Sophie Binay

        Sophie Binay, GM and Chief Scientific Officer

      LocationsView all

      2 locations detected

      • Paris, Île-de-France HQ

        France

        46 Rue Henri Huchard

      • Paris, IDF

        France

        27 Rue du Faubourg Saint-Jacques

      Footer menu